7 pieces of content — guidelines, trials, and news in Diabetes / Metabolic.
The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver…
This study is open to adults who are at least 18 years old living with obesity and have: * a…
This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or primary…
The goal of this clinical trial is to examine the feasibility and acceptability of an online programme that is based…
The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been…
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists…
We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives.
Get weekly clinical updates — guidelines, trials, MHRA alerts — delivered to your inbox. Free for verified HCPs.
By registering you confirm you are a healthcare professional. No spam. Unsubscribe anytime.